Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Barbieri

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|October 3, 2012
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entryAndrew P-A Karalewitz, Zhuji Fu, Michael R Baldwin, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidaseKaterina Capková, Mark S Hixon, Sabine Pellett, et al.
Journal of the American Chemical Society|February 18, 2010
Botulinum neurotoxin A protease: discovery of natural product exosite inhibitorsPeter Silhár, Katerina Capková, Nicholas T Salzameda, et al.
Vaccine|August 16, 2011
Subunit vaccine efficacy against Botulinum neurotoxin subtypesJames S Henkel, William H Tepp, Amanda Przedpelski, et al.
Cellular Microbiology|May 11, 2007
Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoSYue Zhang, Qing Deng, Jaclyn A Porath, et al.
Infection and Immunity|October 31, 2007
Recombinant holotoxoid vaccine against botulismChristina L Pier, William H Tepp, Marite Bradshaw, et al.
The Journal of Biological Chemistry|February 1, 2002
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoSMatthew J Riese, Udo-Michael Goehring, Mary E Ehrmantraut, et al.
Biochemistry|September 1, 2012
Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241Nathan C Simon, James M Vergis, Avesta V Ebrahimi, et al.
Plos One|September 24, 2013
Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cellsSusan R Heimer, David J Evans, Michael E Stern, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1Linda A Stevens, Joseph T Barbieri, Grzegorz Piszczek, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|October 3, 2012
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entryAndrew P-A Karalewitz, Zhuji Fu, Michael R Baldwin, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidaseKaterina Capková, Mark S Hixon, Sabine Pellett, et al.
Journal of the American Chemical Society|February 18, 2010
Botulinum neurotoxin A protease: discovery of natural product exosite inhibitorsPeter Silhár, Katerina Capková, Nicholas T Salzameda, et al.
Vaccine|August 16, 2011
Subunit vaccine efficacy against Botulinum neurotoxin subtypesJames S Henkel, William H Tepp, Amanda Przedpelski, et al.
Cellular Microbiology|May 11, 2007
Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoSYue Zhang, Qing Deng, Jaclyn A Porath, et al.
Infection and Immunity|October 31, 2007
Recombinant holotoxoid vaccine against botulismChristina L Pier, William H Tepp, Marite Bradshaw, et al.
The Journal of Biological Chemistry|February 1, 2002
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoSMatthew J Riese, Udo-Michael Goehring, Mary E Ehrmantraut, et al.
Biochemistry|September 1, 2012
Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241Nathan C Simon, James M Vergis, Avesta V Ebrahimi, et al.
Plos One|September 24, 2013
Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cellsSusan R Heimer, David J Evans, Michael E Stern, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1Linda A Stevens, Joseph T Barbieri, Grzegorz Piszczek, et al.
Pageof 11